Skip to main content
Equibles

Invesco Ltd.

Position in RNA — Atrium Therapeutics, Inc.

CIK 914208 Atlanta, GA
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$190,638
+$54,359 QoQ
Shares Held
14,174
+39.1% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 97% None 3%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. RNA ranks #246 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in RNA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $190,638 14,174
2026-03-31 $136,279 10,193